Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.

Slides:

Advertisements

Similar presentations

J Exp Bot. 2017;68(17): doi: /jxb/erx352

Advertisements

Figure 3: MetaLIMS sample input.

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

Figure 1 The study area within Vienna Zoo is outlined in red

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.

FIGURE 1 Flow chart of patient enrollment and exclusion

Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.

Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.

Figure 1 Flortaucipir PET MUBADA/PERSI SUVr at baseline, 9 and 18 months for individual subjects. Each subject is ... Figure 1 Flortaucipir PET MUBADA/PERSI.

Fig. 1 Mean change from baseline in ANC ± s. e

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).

Figure 1. Brain complexity, consciousness and psychedelics

Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.

Figure 1. Analysis of human TRIM5α protein with Blast-Search and PhyML+SMS ‘One click’ workflow. (A) NGPhylogeny.fr ... Figure 1. Analysis of human TRIM5α.

Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.

Fig. 1 Flow chart for selection of study subjects

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.

FIGURE 1 Malta: a plate-style food guide

Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.

FIGURE 1 Study consort diagram

Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,

Figure 1: Predicted probability of nest presence (0 = no nest and 1 = nest present) in response to canopy cover for ... Figure 1: Predicted probability.

Figure 1. Using Voronoi tessellation to define contacts

Fig. 1. iS-CellR pipeline overview

Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)

Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.

Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.

Figure 1. The configuration menu allows the user to choose among the main visualization/processing options of the ... Figure 1. The configuration menu.

Figure 1. (A) Architecture of Doc2Hpo. (B) Interactive user interface

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.

Figure 1. The framework of NetGO with seven steps

Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a ... Figure 1. Overview of features.

FIGURE 1 Major activities in the working week of a banker

Figure 1 Patient disposition

Figure 1. Trial profile. (A) Part A and (B) part B

Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric.

Figure 1 Distribution of WCD use days in WEARIT-II

Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.

Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.

Figure 1. The proportion of CSBM responders over the 2-week treatment period (A), the proportion of SBM responders by ... Figure 1. The proportion of CSBM.

Figure 1 Genetic results. No case had more than one diagnostic result

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Figure 1. (A) Baseline contrast-enhanced CT scan of melanoma patient presenting with metastases in the liver and lymph ... Figure 1. (A) Baseline contrast-enhanced.

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.

Source:Zimnisky (2014). Source:Zimnisky (2014).

Figure 1 Mechanisms of mitral regurgitation.

FIGURE 1 Changes in lipids and lipoproteins after consuming a Med-Red or Med-Control diet for 5 wk. Results are ... FIGURE 1 Changes in lipids and lipoproteins.

Figure 2. Model adequacy results for the two empirical data sets, West African Ebola, and 2009 H1N1 influenza. The ... Figure 2. Model adequacy results.

Figure 1. Unrooted phylogenetic trees for UL73 and UL74 based on amino acid sequences derived from 243 genome ... Figure 1. Unrooted phylogenetic trees.

Fig. 1. Examples of plots of NanoPlot and NanoComp

Figure 1 ABCDE of primary prevention.2

Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.

Figure 1. Evolutionary process of a policy field.

Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.

Presentation transcript:

Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized acute dehiscence-type defect. (b) Implant insertion and exposed implant surface was treated with bone substitute grafting materials. (c) All defects were covered with Bio-Gide collagen membrane. (d) The flap was carefully closed by the mucoperiosteal flaps for submerged healing Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Regen Biomater, Volume 6, Issue 2, 21 March 2019, Pages 107–111, https://doi.org/10.1093/rb/rby029 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2 The alveolar ridge height of four tested groups after 3 and 6 months of healing. There was no significant ... Figure 2 The alveolar ridge height of four tested groups after 3 and 6 months of healing. There was no significant difference among the test and control groups in either test period Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Regen Biomater, Volume 6, Issue 2, 21 March 2019, Pages 107–111, https://doi.org/10.1093/rb/rby029 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3 Bone volume density of four tested groups after 3 and 6 months of healing. The three types of materials used ... Figure 3 Bone volume density of four tested groups after 3 and 6 months of healing. The three types of materials used in the present study displayed similar bone volume density Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Regen Biomater, Volume 6, Issue 2, 21 March 2019, Pages 107–111, https://doi.org/10.1093/rb/rby029 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 4 Bone complexity of four tested groups after 3 and 6 months of healing. The three types of materials used in ... Figure 4 Bone complexity of four tested groups after 3 and 6 months of healing. The three types of materials used in the present study displayed similar bone complexity Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Regen Biomater, Volume 6, Issue 2, 21 March 2019, Pages 107–111, https://doi.org/10.1093/rb/rby029 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 5 The histological results for the defect area after 6 months of healing. Similar histological results were ... Figure 5 The histological results for the defect area after 6 months of healing. Similar histological results were observed for all of the groups in terms of bone regeneration and osseointegration. TA: the material was a mixture of HA and collagen. TB: the material is biomimetic mineralized collagen; BO : Bio-Oss bone-grafting material; BC: the blank control group contained only bone defects with a collagen membrane Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Regen Biomater, Volume 6, Issue 2, 21 March 2019, Pages 107–111, https://doi.org/10.1093/rb/rby029 The content of this slide may be subject to copyright: please see the slide notes for details.